⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL)

Official Title: Personalized Circulating DNA Follow-up in Melanoma

Study ID: NCT04866680

Conditions

Melanoma

Study Description

Brief Summary: PERCIMEL is an open multicentric study. The purpose of this study is to assess the interest of molecular analysis on circulating tumor DNA in the follow-up of the disease.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

CHU Jean Minjoz, Besançon, , France

CGFL, Dijon, , France

Chu Dijon, Dijon, , France

Chru Lille, Lille, , France

Ghr Mulhouse Sud Alsace, Mulhouse, , France

Institut de Cancerologie de Lorraine, Vandœuvre-lès-Nancy, , France

Chru Nancy, Vandœuvre-lès-Nancy, , France

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: